Skip to main content

Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy.

Publication ,  Journal Article
Jensen, KW; Kerr, KM; Fedullo, PF; Kim, NH; Test, VJ; Ben-Yehuda, O; Auger, WR
Published in: Circulation
September 29, 2009

BACKGROUND: The currently recommended treatment for chronic thromboembolic pulmonary hypertension is pulmonary thromboendarterectomy (PTE). No convincing evidence for the use of pulmonary hypertensive medical therapy (PHT) exists in operable candidates. We sought to determine the prevalence of the use of PHT on referral for PTE and the effects on pre-PTE hemodynamics and post-PTE outcomes/hemodynamics. METHODS AND RESULTS: We performed a retrospective analysis of chronic thromboembolic pulmonary hypertension patients referred for PTE during 2005-2007. The prevalence of PHT was determined for all patients referred to our institution. Hemodynamic and outcomes analysis involved only those undergoing PTE. Data included baseline demographics, PHT medication(s), dosage, duration of therapy, and time to referral. Hemodynamic data were acquired from the time of diagnosis, the time of referral visit, and after PTE. Outcomes included intensive care unit, hospital, and ventilator days; bleeding and infection rates; incidence of reperfusion lung injury; and in-hospital mortality. The control group (n=244) was compared with the PHT group (n=111); subgroups included monotherapy with bosentan, sildenafil, or epoprostenol and combination therapy. The prevalence of PHT significantly increased from 19.9% in 2005 to 37% in 2007. There was minimal benefit of treatment with PHT on pre-PTE mean pulmonary artery pressure, but its use was associated with a significant delay in time to referral for PTE. Both groups experienced significant improvements in hemodynamic parameters after PTE. The 2 groups did not differ significantly in any post-PTE outcome. Similar results were obtained for each subgroup. CONCLUSIONS: Our results suggest that PHT use has minimal effect on pre-PTE hemodynamics and no effect on post-PTE outcomes/hemodynamics.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

September 29, 2009

Volume

120

Issue

13

Start / End Page

1248 / 1254

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Retrospective Studies
  • Reperfusion Injury
  • Referral and Consultation
  • Pulmonary Wedge Pressure
  • Pulmonary Embolism
  • Prevalence
  • Incidence
  • Hypertension, Pulmonary
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jensen, K. W., Kerr, K. M., Fedullo, P. F., Kim, N. H., Test, V. J., Ben-Yehuda, O., & Auger, W. R. (2009). Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation, 120(13), 1248–1254. https://doi.org/10.1161/CIRCULATIONAHA.109.865881
Jensen, Kurt W., Kim M. Kerr, Peter F. Fedullo, Nick Hyong Kim, Victor J. Test, Ori Ben-Yehuda, and William R. Auger. “Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy.Circulation 120, no. 13 (September 29, 2009): 1248–54. https://doi.org/10.1161/CIRCULATIONAHA.109.865881.
Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009 Sep 29;120(13):1248–54.
Jensen, Kurt W., et al. “Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy.Circulation, vol. 120, no. 13, Sept. 2009, pp. 1248–54. Pubmed, doi:10.1161/CIRCULATIONAHA.109.865881.
Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009 Sep 29;120(13):1248–1254.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

September 29, 2009

Volume

120

Issue

13

Start / End Page

1248 / 1254

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Retrospective Studies
  • Reperfusion Injury
  • Referral and Consultation
  • Pulmonary Wedge Pressure
  • Pulmonary Embolism
  • Prevalence
  • Incidence
  • Hypertension, Pulmonary
  • Humans